{"transactions":[{"id":2290181,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":127811,"kind":"person","name":"Gayko Urte","position":1,"cik":"0001559217","reported_name":"Gayko Urte","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-04-26T16:36:58.000Z","date":"2022-04-25","kind":"grant","acquired":true,"shares":400000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on April 25, 2022. The shares underlying the option are scheduled to vest in four equal annual installments over four years."}],"balance_after":400000,"derivative":{"exercise_price":1.93,"expiration_date":"2032-04-25","underlying":"Common Stock","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0001599298-22-000034","document":"wf-form4_165100539719830.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1559217/000159929822000034/wf-form4_165100539719830.xml","form_type":"4"}},{"id":2442856,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":127811,"kind":"person","name":"Gayko Urte","position":1,"cik":"0001559217","reported_name":"Gayko Urte","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-01-05T16:07:22.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":42553,"price":1.13,"value":48084.89,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The option was issued to the reporting person pursuant to the issuer's Director Retainer Option Election Plan in lieu of retainer fees of $48,000."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option was issued on January 3, 2022. The shares underlying the option are scheduled to vest in four equal quarterly installments, on March 31, 2022, June 30, 2022, September 30, 2022, and December 31, 2022."}],"balance_after":67553,"derivative":{"exercise_price":2.82,"expiration_date":"2032-01-03","underlying":"Common Stock","underlying_shares":42553},"source":{"system":"sec-edgar","filing":"0001599298-22-000008","document":"wf-form4_164141681907145.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1559217/000159929822000008/wf-form4_164141681907145.xml","form_type":"4"}},{"id":2442855,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":127811,"kind":"person","name":"Gayko Urte","position":1,"cik":"0001559217","reported_name":"Gayko Urte","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-01-05T16:07:22.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on January 3, 2022. The shares underlying the option are scheduled to vest in equal quarterly installments, on March 31, 2022, June 30, 2022, September 30, 2022, and December 31, 2022."}],"balance_after":25000,"derivative":{"exercise_price":2.82,"expiration_date":"2032-01-03","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001599298-22-000008","document":"wf-form4_164141681907145.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1559217/000159929822000008/wf-form4_164141681907145.xml","form_type":"4"}},{"id":2509997,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":127811,"kind":"person","name":"Gayko Urte","position":1,"cik":"0001559217","reported_name":"Gayko Urte","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-11-16T17:17:44.000Z","date":"2021-11-03","kind":"grant","acquired":true,"shares":4041,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option was granted on November 3, 2021 and represents a pro rata amount of the annual 25,000 option board grant based approximately on the number of days this year the reporting person is anticipated to serve as a director. The shares underlying the option are scheduled to vest in full on December 31, 2021."}],"balance_after":204041,"derivative":{"exercise_price":5.54,"expiration_date":"2031-11-03","underlying":"Common Stock","underlying_shares":4041},"source":{"system":"sec-edgar","filing":"0000921895-21-002700","document":"form412566001_11162021.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1559217/000092189521002700/form412566001_11162021.xml","form_type":"4"}},{"id":2509996,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":127811,"kind":"person","name":"Gayko Urte","position":1,"cik":"0001559217","reported_name":"Gayko Urte","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-11-16T17:17:44.000Z","date":"2021-11-03","kind":"grant","acquired":true,"shares":200000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on November 3, 2021. The shares underlying the option are scheduled to vest in four equal annual installments, with the first such installment occurring on November 3, 2022."}],"balance_after":200000,"derivative":{"exercise_price":5.54,"expiration_date":"2031-11-03","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0000921895-21-002700","document":"form412566001_11162021.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1559217/000092189521002700/form412566001_11162021.xml","form_type":"4"}}]}